Report - Follow up EMA and EORTC multi-stakeholder workshop on soft tissue and bone sarcoma

Human medicines European public assessment report (EPAR): Akeega, niraparib,abiraterone acetate, Date of authorisation: 19/04/2023, Revision: 1, Status: Authorised

Agenda of the CHMP written procedure 19-22 August 2024

NovoSeven

Human medicines European public assessment report (EPAR): Myozyme, alglucosidase alfa, Date of authorisation: 28/03/2006, Revision: 31, Status: Authorised

Human medicines European public assessment report (EPAR): Insulin lispro Sanofi, insulin lispro, Date of authorisation: 19/07/2017, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Granupas (previously Para-aminosalicylic acid Lucane), para-aminosalicylic acid, Date of authorisation: 07/04/2014, Revision: 13, Status: Authorised

Guide to CTIS training material catalogue

Clinical Trial Information System (CTIS) - Sponsor handbook

Sponsors' guide: Transition of trials from EudraCT to CTIS - CTIS Training Programme - Module 23